Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exosome-based Nanoplatform for Ldlr mRNA Delivery in Familial Hypercholesterolemia

NCT05043181 is registered in ClinicalTrials.gov with Tang-Du Hospital as lead sponsor.

NCT NCT05043181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05043181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exosome-based Nanoplatform for Ldlr mRNA Delivery in Familial Hypercholesterolemia
Lead sponsor
Tang-Du Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
December 31, 2021
Completion date
December 31, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familial hypercholesterolemia